In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae
Sci Rep. 2023 Sep 2;13(1):14429. doi: 10.1038/s41598-023-39647-9. PMID: 37660210
Marta Gómara-Lomero, Ana Isabel López-Calleja, Antonio Rezusta, José Antonio Aínsa, Santiago Ramón-García
URL:
https://pubmed.ncbi.nlm.nih.gov/37660210/